血压升高、降压药物与骨骼健康:重新审视旧假说并探索未来研究方向
该综述指出血压与骨代谢在生理调节上存在共性,特定降压药类别也可能影响骨密度,但现有观察性研究和随机试验证据不足以确立血压及降压药使用与骨质疏松和骨折风险之间的因果关系。文章认为,大规模生物医学数据的可及性以及研究设计和分析方法的进展,为更可靠、更细致地检验血压与骨骼健康关联提供了机会。
要点
- 现有证据不足以确立血压或降压药与骨质疏松和骨折风险的因果关系。
- 大规模生物医学数据和研究设计进展为更可靠检验该关联提供机会。
- 血压升高患病率高且降压药广泛处方,即使小效应在人群层面也可能重要。
核心结论
- 当前证据不足以确立血压及降压药使用与骨骼健康结局(尤其骨质疏松和骨折风险)的因果关系。
- 需借助大规模生物医学数据及研究设计与分析方法的进展来更可靠地检验该关联。
- 血压升高患病率高且降压药广泛使用,即使小效应在人群层面也可能重要。
研究设计与样本
- 本文为综述,讨论血压与骨代谢的生理调节共性及降压药类别对骨密度的可能影响。
- 文中未报告系统检索范围或纳入研究数量。
主要发现
- 血压与骨代谢在生理调节上似乎存在共性。
- 特定降压药物类别可能影响骨密度。
- 现有观察性研究和随机试验证据不足以确立血压及降压药与骨骼健康结局的因果关系。
临床怎么用
- 临床解读血压与骨骼健康关联时应认识到现有证据尚不足以支持因果推断。
- 关注降压药对骨密度和骨折风险的可能影响,但避免基于现有证据做出确定性结论。
局限性
- 现有观察性研究和随机试验证据不足以确立因果关系。
- 单一数据来源或研究设计不太可能提供确定性答案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Blood pressure and bone metabolism appear to share commonalities in their physiologic regulation. Specific antihypertensive drug classes may also influence bone mineral density. However, current evidence from existing observational studies and randomised trials is insufficient to establish causal associations for blood pressure and use of blood pressure-lowering drugs with bone health outcomes, particularly with the risks of osteoporosis and fractures. The availability and access to relevant large-scale biomedical data sources as well as developments in study designs and analytical approaches provide opportunities to examine the nature of the association between blood pressure and bone health more reliably and in greater detail than has ever been possible. It is unlikely that a single source of data or study design can provide a definitive answer. However, with appropriate considerations of the strengths and limitations of the different data sources and analytical techniques, we should be able to advance our understanding of the role of raised blood pressure and its drug treatment on the risks of low bone mineral density and fractures. As elevated blood pressure is highly prevalent and blood pressure-lowering drugs are widely prescribed, even small effects of these exposures on bone health outcomes could be important at a population level.
引用
- Canoy D, Harvey NC, Prieto-Alhambra D, et al. Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions. Osteoporos Int. 2021. PMID: 34642814. doi:10.1007/s00198-021-06190-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。